![](/img/cover-not-exists.png)
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study
Rahal, S., Boher, J M, Extra, J M, Tarpin, C., Charafe-Jauffret, E., Lambaudie, E., Sabatier, R., Thomassin-Piana, J., Tallet, A., Resbeut, M., Houvenaeghel, G., Laborde, L., Bertucci, F., Viens, P.,Volume:
15
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-015-1746-3
Date:
December, 2015
File:
PDF, 1.01 MB
english, 2015